HIGHLIGHTS
- who: Aimee Rendell and collaborators from the Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia have published the paper: Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?, in the Journal: Biomedicines 2022, 2113 of /2022/
- what: The study showed that the protein expressions of VEGF-A, VEGF-D, and VEGFR1 were higher in the metastases than the primary lesions .
- future: Whilst further study will be required to dissect the exact mechanism of each receptor in isolation the ROR family represents a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.